Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?
about
Weight control and prevention of metabolic syndrome by green tea.Selecting data elements to build a patient-centric electronic health record that will support adherence to therapeutic lifestyle change.Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trialFatty acid- and cholesterol transporter protein expression along the human intestinal tract.NXCL-4950, a novel composite applicable to peripheral skin, is capable of increasing skin temperature by enhancing capillary circulation.High-normal blood pressure and long-term risk of type 2 diabetes: 35-year prospective population based cohort study of men.Efficacy of lifestyle interventions in physical health management of patients with severe mental illness.Metabolic syndrome and hepatic resection: improving outcomeGenetic variations of HSPA1A, the heat shock protein levels, and risk of atherosclerosisSerum amyloid A impairs the antiinflammatory properties of HDLAgreement Between Results of Home Sleep Testing for Obstructive Sleep Apnea with and Without a Sleep Specialist.Motivational interviewing to reduce cardiovascular risk in African American and Latina women.Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort StudyTime to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome.Dietary fat intake in the European Prospective Investigation into Cancer and Nutrition: results from the 24-h dietary recalls.Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels.
P2860
Q27687558-4E8C39A7-866E-4027-966B-FBC618472E36Q33383518-8ABA6577-E58E-4B1A-B486-D073B5BE7387Q33736919-C9AA37EC-D78A-42EB-8C6F-94AD89512AD3Q33818527-27665924-0A46-475C-BD4E-B275FD4B09D7Q34420075-90248BD7-CD6C-4E56-BE13-B21FCFCC740CQ34445919-B314658F-B6C2-422D-98DC-32A14732A1FAQ35290463-2DCBE477-0873-41AC-A8EF-426AF521B65AQ35629684-D86BA303-9794-4AFD-8221-C03EB90E0230Q36010531-DAD08A83-310E-4EC9-A076-C6F3D9FE6856Q36430779-2301161A-D9FC-4E32-A5E0-2B8D8304F726Q37059510-CF83E65C-8F86-41F9-9CE6-3B3BF8F39BD0Q38116714-6F413392-C576-4C93-AEA5-26E96F109ABDQ38829782-DA1F200F-7F41-4970-A0C4-DAAD6C4B53F2Q42956394-9919CEB0-2B93-4FCE-B8EC-A04EC2CF2B69Q43248931-D2A239A1-B79C-4558-911E-5574B48A89C3Q47740085-E866D6CB-DF2A-4C27-8AC1-C06B782192DA
P2860
Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular and metabolic r ...... omes in the high-risk patient?
@en
type
label
Cardiovascular and metabolic r ...... omes in the high-risk patient?
@en
prefLabel
Cardiovascular and metabolic r ...... omes in the high-risk patient?
@en
P1476
Cardiovascular and metabolic r ...... omes in the high-risk patient?
@en
P2093
Scott M Grundy
P304
S3-8; discussion S9
P356
10.1016/J.AMJMED.2007.06.005
P407
P433
P577
2007-09-01T00:00:00Z